Evidence supporting the use of: Oligomeric proanthocyanidins
For the health condition: Capillary Weakness

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Oligomeric proanthocyanidins (OPCs), primarily derived from sources like grape seed extract and pine bark, have been studied for their effects on vascular health, including capillary strength and permeability. Several clinical and preclinical studies suggest that OPCs exert protective effects on blood vessels by stabilizing collagen and elastin, major structural components of capillary walls. These compounds act as potent antioxidants, reducing oxidative stress that can weaken capillary integrity. Some human studies have demonstrated that OPC supplementation can reduce symptoms of capillary fragility such as easy bruising, edema, and microbleeds, especially in populations with chronic venous insufficiency or diabetic microangiopathy. Additionally, OPCs have been observed to inhibit enzymatic degradation of connective tissue, further supporting vascular resilience.

While the evidence base is not as large or conclusive as for some pharmaceutical agents, systematic reviews and meta-analyses have generally found a positive effect of OPCs on microvascular function and capillary resistance. The European Medicines Agency and other regulatory bodies acknowledge the traditional and emerging clinical use of OPC-rich extracts for supporting capillary health. However, variability in study design, dosage, and extract standardization means more high-quality trials are warranted. Overall, the scientific support for using OPCs to address capillary weakness is moderate, with a reasonable biological rationale and some supportive clinical data.

More about Oligomeric proanthocyanidins
More about Capillary Weakness

Products containing Oligomeric proanthocyanidins

We currently have no products on Vitabase that contain this ingredient.